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ERCC1–XPF cooperates with CTCF and cohesin
to facilitate the developmental silencing of
imprinted genes
Georgia Chatzinikolaou1,4, Zivkos Apostolou1,2,4, Tamara Aid-Pavlidis1, Anna Ioannidou1,2,
Ismene Karakasilioti1,5, Giorgio L. Papadopoulos2,3, Michalis Aivaliotis1, Maria Tsekrekou1,2, John Strouboulis1,3,
Theodore Kosteas1 and George A. Garinis1,2,6
Inborn defects in DNA repair are associated with complex developmental disorders whose causal mechanisms are poorly
understood. Using an in vivo biotinylation tagging approach in mice, we show that the nucleotide excision repair (NER)
structure-specific endonuclease ERCC1–XPF complex interacts with the insulator binding protein CTCF, the cohesin subunits
SMC1A and SMC3 and with MBD2; the factors co-localize with ATRX at the promoters and control regions (ICRs) of imprinted
genes during postnatal hepatic development. Loss of Ercc1 or exposure to MMC triggers the localization of CTCF to
heterochromatin, the dissociation of the CTCF–cohesin complex and ATRX from promoters and ICRs, altered histone marks
and the aberrant developmental expression of imprinted genes without altering DNA methylation. We propose that ERCC1–XPF
cooperates with CTCF and cohesin to facilitate the developmental silencing of imprinted genes and that persistent DNA damage
triggers chromatin changes that affect gene expression programs associated with NER disorders.
To counteract DNA damage, mammalian cells have evolved partially
overlapping DNA repair systems to remove DNA lesions and
restore their DNA back to its native form1,2. For bulky helix-
distorting ultraviolet (UV)-induced DNA lesions, the principal repair
mechanism is the evolutionarily conserved nucleotide excision repair
(NER) pathway3. NER recognizes and removes helical distortions
throughout the genome, that is, global genome NER, or selectively
from the transcribed strand of active genes, that is, transcription-
coupled repair. The NER structure-specific endonucleases XPG and
ERCC1–XPF cleave on the 3′ and 5′ side of the DNA lesion,
respectively, to release a 24–32-nucleotide fragment containing the
damaged DNA4–6. Besides NER, the ERCC1–XPF complex also
participates in the repair of DNA interstrand crosslinks (DNA ICLs)7,8
and for the completion of homologous recombination at DNA
replication forks stalled by DNA ICLs9,10.
In humans, mutations in NER genes lead to the skin cancer-prone
xeroderma pigmentosum or to a heterogeneous group of premature
ageing-like (progeroid) disorders, including Cockayne syndrome
(associated genes:Csa,Csb,Xpd,Xpb) and trichothiodystrophy (TTD;
associated genes: Xpd, Xpb)11–15. Patients with subtle mutations in
Xpf show mild xeroderma pigmentosum features and develop cancer
during adulthood16. Instead, a patient with an Ercc1mutation showed
severe clinical abnormalities coupled with a relatively mild DNA
repair defect17. This and the fact that a complete defect in NER
is compatible with life18 argues for XPF–ERCC1 having functions
outside the canonical NER11.
Indeed, NER factors are now known to play a role, in addition
to DNA repair, in the regulation of gene expression19,20, chromatin
looping21, the transcriptional reprogramming of pluripotent stem
cells22 and the fine-tuning of growth-promoting genes during
postnatal development23. At present, however, no solid evidence exists
as to how NER is functionally involved in these processes, what are
the NER-bound protein factors involved and their in vivo relevance
to NER disorders. To tackle this, we used an in vivo biotinylation
tagging approach inmice andmutant animals to dissect the functional
contribution of ERCC1–XPF during liver development.
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Figure 1 Generation of NER-proficient, biotin-tagged XPF animals.
(a) Schematic representation of knock-in mice expressing the NER structure-
specific endonuclease XPF fused with the 15-amino-acid Avi tag sequence, a
3×Flag tag and a tobacco etch virus (TEV) site separating the two tags. EcoRI
and HindIII sites are synthetic; B, Flag-Tev-Avi fragment. (b,c) Two positive
embryonic stem cell clones (marked with arrow) were used to generate germ-
line-transmitting chimaeras that were backcrossed with C57Bl/6 mice to
generate avXpf+/− pups, as confirmed by Southern blot (b) and PCR (c). (d)
Anti-HA immunoblot showing expression of the BirA biotin ligase protein
(relative molecular mass, 37,000) in different tissues of 2-month-old BirA
transgenic animals. (e) In vivo biotinylation of the short 15-amino-acid Avi tag
in bXPF animals. Nuclear extracts from P15 avXPF livers expressing either
only avXPF (XPF; relative molecular mass, 110,000) or avXPF and BirA
biotin ligase (bXPF) were tested by western blot. The blot was probed with
streptavidin-HRP (strp-HRP), which confirms biotinylation of XPF in vivo,
with anti-Flag and anti-HA confirming the presence of the knock-in allele
and of the BirA transgene, respectively. (f) Biotinylation efficiency in bXPF
livers. The percentage of biotinylated XPF (97%) and flow-through (3%; fth)
was calculated by performing pull-down with 1mg of nuclear extract derived
from 15-day-old bXPF livers and M-280 paramagnetic beads in excess.
(g) Number of WT, bXPF and BirA pups born. (h) Weight (grams; g) of WT and
bXPF animals at the indicated time points (n=3 mice per time point and
genotype). (i) A photograph of 20-day bXPF and BirA animals. (j,k) Survival
of primary bXPF and WT MEFs to UV (j) or to MMC (k) at the indicated
doses (n=3 dishes per dose per genotype). (l) UV-induced unscheduled
DNA synthesis in primary bXPF and WT MEFs (number of positive stained
cells; n=3 dishes per genotype per treatment). Error bars, standard deviation
(s.d.). Statistical source data are provided in Supplementary Table 6.
RESULTS
Generation of biotin-tagged XPF mice
We generated knock-in mice expressing the NER structure-specific
endonuclease XPF fused carboxy terminally before the stop codon of
the last exon 11 with a 15-amino-acid tandem affinity purification
(TAP) tag biotinylatable sequence24 and a 3× Flag tag separated
by a tobacco etch virus protease cleavage site for easy tag removal
(Fig. 1a). After transfection in 129/SV embryonic stem cells expressing
the Protamine 1-Cre recombinase transgene to efficiently excise the
neomycin cassette in the male germ line25 and selection of properly
targeted clones (Fig. 1a and Methods), we used two independent
transfected clones to generate germ-line-transmitting chimaeras
(Fig. 1b,c). TAP-tag-fused heterozygous males (avXpf +/−) were
backcrossed andmaintained in a C57BL/6J background. Homozygous
avXpf +/+ knock-in mice were then crossed with mice broadly
expressing the HA-tagged bacterial BirA biotin ligase transgene
under the control of the human hnRNPA2B1/CBX3 methylation-free
island26 (Fig. 1d and Supplementary Fig. 1A). BirA is a bacterial ligase
that specifically recognizes and efficiently biotinylates the 15-amino-
acid avidinwithin the short 15-amino-acid tag (Fig. 1e,f), thus creating
a high-affinity ‘handle’ for the in vivo isolation of XPF-bound protein
complexes from protein extracts isolated from biotin-tagged XPF
(bXPF) mice by binding to streptavidin. Unlike Ercc1−/− or Xpf −/−
mice27,28, bXPF animals are born at the expectedMendelian frequency
(Fig. 1g), grow normally (Fig. 1h) and show no developmental defects
or other pathological features (Fig. 1i). Importantly, primary bXPF
mouse embryonic fibroblasts (MEFs) show no hypersensitivity to UV
(Fig. 1j) or to the DNA crosslinker mitomycin C (MMC; Fig. 1k) and
no detectable differences in UV-induced unscheduled DNA synthesis
when compared to wild-type (WT) control MEFs (Fig. 1l). Thus,
bXPF animals develop normally to adulthood and are NER- and DNA
ICL-repair-proficient.
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Figure 2 ERCC1–XPF interacts with protein complexes involved in genome
organization and chromosome architecture. (a) Schematic representation
of the high-throughput MS analysis in the livers derived from P15 bXPF
animals expressing the BirA transgene (n=15) and BirA transgenic mice
(n=15). (b) Venn diagram of bXPF-bound protein factors from three
independent pulldowns (PD) and subsequent MS analyses. (c) Hierarchical
clustering of the signal intensities of 306 bXPF-bound proteins in P15 bXPF
and BirA livers. (d) List of significantly over-represented biological processes
of 140 shared XPF-bound proteins. The biological processes are sorted
by the −log of the P value, which is calculated by Fisher’s exact test
right-tailed. The black line marks the threshold of significance at P≤0.05.
Count: the number of identified XPF-bound protein factors involved in
the indicated biological process; % depicts the percentage of XPF-bound
proteins involved in the indicated biological process over the total number of
XPF-bound proteins (e). Number of observed (obs.) and expected (exp.) known
protein interactions within the core 65 XPF-bound protein set. (f) Schematic
representation of the four major XPF-bound protein complexes involved based
on experimental (exp.) evidence and/or text mining (text) evidence, hom:
homologous proteins. fth: flow-through. Unprocessed original scans of blots
are shown in Supplementary Fig. 8.
A proteomics strategy reveals ERCC1–XPF protein conjugates
involved in genome organization and chromosome architecture
To isolate and characterize NER-associated protein complexes during
postnatal murine development, we prepared nuclear extracts from
P15 avXPF; BirA livers (designated as bXPF) and livers expressing
only the BirA transgene using high-salt extraction.Next, we confirmed
that bXPF can still interact with known protein partners involved
in NER, that is, ERCC1 (ref. 11), or transcription, that is, TAF10
(ref. 23) (Fig. 2a and Supplementary Fig. 8A). We then separated the
bound protein interactome by one-dimensional SDS–PAGE followed
by in-gel digestion (∼12 slices) and peptides were further separated
and analysed with high-resolution liquid chromatography–tandem
mass spectrometry (nLC-ESI-MS/MS) on a hybrid linear ion trap
Orbitrapmass spectrometer (Fig. 2a). From three biological replicates,
we identified a total of 306 proteins (Supplementary Table 1)
with 140 proteins (45.7%) shared in all three measurements under
stringent selection criteria (Fig. 2b and Supplementary Table 2; see
Methods). Using a hierarchical clustering approach, we confirmed
that the 306 bXPF-bound proteins are capable of classifying the
bXPF knock-in and BirA transgenic livers into the expected groups
(Fig. 2c). At the confidence interval used, that is, false discovery
rate (FDR) < 0.05, the significantly over-represented GO terms
found (Fig. 2d) involved 65 out of the initial 140 XPF-bound core
proteins; this set of proteins showed a significantly higher number
of known protein interactions (that is, 63 interactions) than expected
by chance (that is, 28 interactions; Fig. 2e) indicating a functionally
relevant and interconnected protein network. Using this data set,
we were able to discern four major XPF-bound protein complexes
involved in: transcription silencing; transcription initiation; DNA
replication; and DNA repair (Fig. 2f; shown in this order). These
findings confirm previously documented interactions of ERCC1–XPF
with components of the TFIID complex23 and NER11, whilst they
reveal interactions of ERCC1–XPF with factors associated with
transcription repression and DNA replication; the latter probably
reflects the functional role of the ERCC1–XPF complex in homologous
recombination repair.
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Ablation of Ercc1 gene triggers aberrant expression of
imprinted genes during hepatic development
ERCC1–XPF is a highly conserved heterodimeric complex. Ercc1−/−
mice are growth-defective, show progeroid features in several
organs and die of liver failure within a month after birth29,30.
Streptavidin pulldown identified CTCF co-purifying with bXPF
under native (micrococcal nuclease digested) chromatin conditions
(Supplementary Fig. 1B). This and our findings that XPF interacts
with proteins known to be involved in chromatin organization and
gene silencing, that is, CTCF, SMC1A, SMC3 andMBD2 (refs 31–33),
prompted us to examine their relevance to the developmental defects
seen in Ercc1−/− animals34. Co-immunoprecipitation experiments
confirmed that a portion of endogenous ERCC1 interacts with
CTCF, SMC1A, SMC3 and MBD2 in P15 livers; the protein–protein
interactions were not affected by treating the extracts with benzonase
(Fig. 3ai and Supplementary Fig. 8B). An antibody raised against
CTCF confirmed the reciprocity of the interactions (Fig. 3aii and
Supplementary Fig. 8B). We also challenged the specificity of ERCC1
interactions in Ercc1−/− livers (Fig. 3bi and Supplementary Fig. 8B);
notably, CTCF, SMC1A, SMC3 and MBD2 interact in Ercc1−/− livers
(Fig. 3bii and Supplementary Fig. 8B).
The functional role of CTCF, the cohesin and MBD2 in genomic
imprinting or the postnatal silencing of distinct genes is well docu-
mented32,33,35,36. Imprinted genes are expressed in a parent-of-origin-
specific manner already established in the gametes37. During embryo-
genesis only one parental allele is expressed, while the other allele
is silenced35. Soon after birth, the remaining active allele of several
imprinted genes is also silenced38. Using liver gene expression data
sets39, we evaluated the gene expression profiles of 68 imprinted genes
in P15 livers derived from NER mutant animals displaying severe
(Csbm/m/Xpa−/−, Ercc1−/−), mild (XpdTTD, Csbm/m) or no signifi-
cant (Xpa−/−) developmental/progeroid defects23,30,40,41 (Supplemen-
tary Table 3). Unlike Csbm/m, Xpa−/− or XpdTTD livers, we find that 22
out of the 68 imprinted genes show significantly aberrant gene expres-
sion profiles in P15Ercc1−/− livers (P<0.05; fold change>±1.2)with
no preference for genes expressed from the maternal or the paternal
allele (Supplementary Table 4); the great majority of imprinted genes
showed increased messenger RNA levels (17 out of 22; Fig. 3c) and
associate with GO terms related to developmental and endocrine
disorders (Supplementary Fig. 1C). A deregulation in the expres-
sion of eight imprinted genes was also observed in Csbm/m/Xpa−/−
livers (Fig. 3c). For further studies, we focused on insulin growth
factor-2 (Igf2), the paternally expressed gene 3 (Peg3), the protein
delta homologue 1 (Dlk1) and the growth factor receptor-bound
protein 10 (Grb10) genes in the Ercc1−/− and WT animals during
hepatic development42–45.
The Igf2, Peg3, Dlk1 and Grb10 genes showed a progressive
postnatal decline inmRNA levels comparedwith E18.5 that inCsbm/m,
Xpa−/− and WT livers led to barely detectable levels at day P60
(Fig. 3d). Instead, in Ercc1−/− livers, we find a gradual but steady
postnatal increase in the mRNA levels of these genes when compared
with age-matched WT livers (Fig. 3e). To test whether the increased
mRNA levels in P15 Ercc1−/− livers reflect an embryonic defect in
genome imprinting or a defect in the postnatal silencing of imprinted
genes, we extended our studies in E18.5 Ercc1−/− fetal livers. Despite
the marginally smaller size of the ERCC1-null embryos (Fig. 3f),
we find no significant differences in the mRNA levels of Igf2, Peg3,
Dlk1 and Grb10 genes in E13.5 Ercc1−/− livers compared with age-
matched WT controls (Fig. 3g). To determine the allelic source of
imprinted gene transcripts in P15 Ercc1−/− livers, we identified a
single polymorphic site within exon 9 of the Peg3 gene in P15
Ercc1−/− livers that are generated when FVB Ercc1−/+ females are
crossed with C57BL/6J Ercc1−/+ males; Peg3 is maternally methylated
and is expressed solely from the paternal allele in the liver44. Our
analysis revealed that the increased expression of the Peg3 gene was
not due to reactivation of the maternal allele, because transcripts
were still derived solely from the paternal allele (Fig. 3h). Further
analysis revealed increased Igf2, Grb10, Peg3, Meg3, Atp10a, H13
and Airn mRNA levels in the kidney, white adipose tissue, pancreas,
cerebellum and spleen of the P15 ERCC1-defective animals, compared
with age-matched WT animals (Fig. 3i and Supplementary Fig. 1D).
Interestingly, Ercc1 inactivation in aP2-Ercc1F/− animals occurs at
∼P15 in mature adipocytes46 when imprinted gene expression has
already been established. Thus, unlike other NER-defective animals,
a defect in ERCC1–XPF triggers the aberrant postnatal expression of
a subset of imprinted genes.
Aberrant histone modifications and recruitment of factors
associated with transcription initiation at the promoters of
imprinted genes in Ercc1−/− livers
A series of chromatin immunoprecipitation (ChIP) studies in
P15 Ercc1−/− livers revealed that RNAPII assembles together with
the basal transcription factors TFIIB, XPD (TFIIH subunit) and TBP
(TFIID) on promoters in P15 Ercc1−/− livers (Fig. 4a). Unlike WT
livers, we also find the loss of repressive histone H3K9 trimethylation
and H3K27 trimethylation marks and a concomitant increase of
activating acetylated histone H3K9Ac and H3K4 trimethylation
on Igf2, Peg3, Dlk1 and Grb10 gene promoters in P15 Ercc1−/−
livers (Fig. 4b).
Genomic imprinting is established already in gametes by parent-
of-origin-specific epigenetic marks, such as DNA methylation47. We,
therefore, examined theDNAmethylation status of the Igf2,Peg3,Dlk1
and Grb10 promoters, the Peg3, H19/Igf2 (from now on designated
as H19) and Meg3/Dlk1 intergenic differentially methylated region
(DMR) (from now on designated as Meg3) ICRs and the Grb10
DMR in P15 Ercc1−/− and WT livers. Using a bisulfite conversion
and sequencing assay on well-defined CTCF- and RNAPII-bound
loci in Peg3, H19 and Meg3 ICRs and Grb10 (CGI2)/Meg3 DMRs
(Fig. 4c and Supplementary Fig. 2A,G), we detected no difference
on methylation in Ercc1−/− compared to WT livers. The H19/Igf2
genomic domain is regulated by long-range chromatin interactions
in the liver, a process mediated in part by the DMRs and their DNA
methylation state48,49. However, similar to ICRs, the DNAmethylation
state was also preserved in the Igf2 DMR1 regulatory region in
both WT and Ercc1−/− livers (Fig. 4c). Loss of ERCC1 in the liver
resulted in reducedmethylation of the Peg3 promoter (Supplementary
Fig. 2B; as shown), but no change in DNA methylation was observed
between Ercc1−/− and WT livers at the CTCF peak within the
Grb10 region, the Igf2 promoters 2 and 3, and the Grb10 promoter
(Supplementary Fig. 2C–F; as shown). Thus, in P15 Ercc1−/− livers,
the increased mRNA levels of imprinted genes occurs without
affecting DNA methylation in ICRs or the DMRs.
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Figure 3 Ablation of the Ercc1 gene triggers the aberrant expression
of imprinted genes during postnatal hepatic development. (a) Co-
immunoprecipitation experiments using anti-ERCC1 (i) or anti-CTCF (ii) in
nuclear extracts from P15 livers analysed by western blotting for SMC1A,
SMC3, MBD2, CTCF and ERCC1 as indicated. (b) Co-immunoprecipitation
experiments using anti-ERCC1 (i) or anti-CTCF (ii) in nuclear extracts from
P15 Ercc1−/− livers analysed by western blotting for the indicated protein
factors. The input and flow-through are 1/20 of the extract used. Unprocessed
original scans of blots are shown in Supplementary Fig. 8B. (c) Number
of significantly aberrantly expressed imprinted genes in P15 Ercc1−/−,
Csbm/m/Xpa−/−, Csbm/m, Xpa−/− and XpdTTD livers. (d) Quantitative PCR
(qPCR) mRNA levels of Igf2, Peg3, Dlk1 and Grb10 genes in Csbm/m,
Xpa−/−, Ercc1−/− and WT livers (as shown) at the indicated time points
compared with corresponding E18.5 (E), (n=3 biological replicates each
representing a pool of 4–5 livers per time point and genotype; error bars,
standard error of the mean (s.e.m.)). (e) qPCR mRNA levels of Igf2, Peg3,
Dlk1 and Grb10 genes in Ercc1−/− livers at the indicated time points
as compared with age-matched littermate WT control livers (n= 3 livers
per time point and genotype; error bars, s.e.m.; two-tailed t-test). (f) A
photograph of E13.5 Ercc1−/− and WT littermate embryos. (g) qPCR mRNA
levels of Igf2, Peg3, Dlk1 and Grb10 genes in E13.5 Ercc1−/− and WT
livers (as shown; n= 3 biological replicates each representing a pool of
4–5 livers per genotype). Red dotted line, WT mRNA levels. Error bars,
s.d. (h) Allele-specific mRNA analysis revealing that increased levels of
Peg3 transcripts are derived only from the paternal (C57BL/6J) allele; no
expression is detected from the maternally imprinted allele (FVB) (n= 3
livers per genotype). Error bars, s.d.; two-tailed t-test. (i) qPCR mRNA
levels of imprinted genes in P15 Ercc1−/− white adipose tissue (WAT, n=3
biological replicates each representing a pool of 4–5 tissues per genotype).
Error bars, s.d.; two-tailed t-test. Red dotted line, WT mRNA levels;
E, E18.5; ∗P≤0.05. Statistical source data are provided in Supplementary
Table 6.
Disruption of Ercc1 leads to the dissociation of the
CTCF–cohesin–MBD2 interacting factors from the promoters
and ICRs of imprinted genes
ChIP followed by qPCR on the well-characterized CTCF- and
RNAPII-bound H19, Igf2, Dlk1/Meg3, Peg3 and Grb10 target
sequences (Supplementary Fig. 2A) showed that bXPF assembles with
CTCF, SMC1A, SMC3 and MBD2 on promoters (Supplementary
Fig. 3A) and the ICRs/DMR (Fig. 5a) in P15 WT livers but not
in CTCF-negative regions (Supplementary Fig. 3B). We also find
ATP-dependent helicase ATRX to recruit to the respective promoters
and the ICRs (Supplementary Fig. 3A and Fig. 5a); ATRX was found
to interact with bXPF in our proteomics studies and is known to
cooperate with cohesin in silencing a subset of imprinted genes
during postnatal murine brain development32. ChIP for CTCF or
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Figure 4 Aberrant histone post-translational modifications and recruitment of
factors associated with transcription initiation at the promoters of imprinted
genes in Ercc1−/− livers. (a) ChIP signals (shown as fold enrichment) of
protein factors associated with transcription initiation (as indicated) at the
Igf2, Peg3, Dlk1 and Grb10 proximal promoter regions in P15 Ercc1−/−
livers as compared with age-matched WT controls; n=3 biological replicates
each representing a pool of 4–5 livers per genotype. ChIP signals were
expressed as fold enrichment over those obtained with control antibody
(IgG), which were set as 1 (red dotted line). Error bars, s.d.; two-tailed
t-test. (b) ChIP signals (shown as fold enrichment) of activating H3K9Ac,
H3K4me3 and repressive H3K9me3, H3K27me3 histone marks at the Igf2,
Peg3, Dlk1 and Grb10 proximal promoter regions in P15 Ercc1−/− livers
as compared with age-matched WT controls; n= 3 biological replicates
each representing a pool of 4–5 livers per genotype. ChIP signals are
expressed as in a. Error bars indicate s.e.m. among replicates; two-tailed
t-test. (c) Schematic representation of the percentage of DNA methylation at
the Igf2, H19, Peg3, Meg3 and Grb10 ICRs/DMRs in P15 Ercc1−/− and
WT livers. Black circles, methylated cytosine; open circles, unmethylated
cytosine, ∗P ≤0.05. Statistical source data are provided in Supplementary
Table 6.
SMC1A and re-ChIP for SMC3, ERCC1, Flag-tagged XPF, MBD2
and ATRX showed that these factors co-occupy the H19 and Peg3
ICRs (Fig. 5b). Instead, ChIP signals for all factors tested were
significantly reduced in promoters and the ICRs in P15 Ercc1−/−
livers compared with WT controls (Fig. 5c and Supplementary
Fig. 3C). Thus, the ERCC1–XPF complex is required for the
optimal promoter and ICR assembly of protein complexes that
associate with the postnatal silencing of imprinted genes in the
developing liver.
CTCF, SMC1A, SMC3 and ATRX are known to display allele-
specific binding at imprinted loci32,33,35,36. We, therefore, envisioned
a similar scenario for ERCC1–XPF in the developing liver. ChIP
followed by allele-specific restriction digest analysis of amplified DNA
in P15 bXPF/SPRET/EiJ F1 livers that are polymorphic within the
Peg3 and H19 ICRs showed that CTCF, SMC1A and SMC3 are
preferentially enriched on the maternal and the paternal allele of the
H19 and Peg3 ICRs, respectively (Fig. 5d); MBD2 and ATRX are
preferentially recruited at the paternal and the maternal alleles of the
H19 and Peg3 ICRs, respectively. The observation that CTCF and
ATRX are localized to opposite alleles in H19 and Peg3 ICRs was
unexpected as ERCC1–XPF assembles with these factors on ICRs
(Fig. 5a) and interacts with CTCF and ATRX in P15 livers (Fig. 2
and Fig. 3a,b). We, therefore, reasoned that the ERCC1–XPF complex
resides in both the paternal and the maternal alleles of H19 and Peg3
ICRs. In line, allele-specific restriction digest analysis of amplified
immunoprecipitated or pulled-downDNA inP15 bXPF/SPRET/EiJ F1
livers showed no allele preference for either ERCC1 or bXPF on the
ICRs (Fig. 5d).
Persistent DNA damage signalling triggers aberrant CTCF
localization and the dissociation of the CTCF, the cohesin
complex and MBD2 from promoters and ICRs
Confocal imaging in WT, Csbm/m, Xpa−/− and Xpc−/− primary
MEFs revealed that CTCF is distributed throughout the nucleoplasm.
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Figure 5 Dissociation of the CTCF–cohesin complex and MBD2 from the
promoters and ICRs of imprinted genes in Ercc1−/− livers. (a) bXPF, CTCF,
SMC1A, SMC3, MBD2 and ATRX ChIP signals are shown as fold enrichment
of the percentage of input antibody over the percentage of input BirA (for
bXPF) or control antibody (IgG) at theH19, Peg3,Meg3 and Grb10 ICRs/DMR
in P15 WT mouse livers (n=3 biological replicates each representing a pool
of 4–5 livers). Error bars, s.d.; two-tailed t-test. (b) ChIP with antibodies
raised against CTCF (top panel) or SMC1A (bottom panel) and re-ChIP
with antibodies raised against SMC1A (top panel) or CTCF (bottom panel)
and SMC3, ERCC1, Flag-tagged XPF, MBD2 and ATRX (both panels). (c)
CTCF, SMC1A, SMC3, MBD2 and ATRX ChIP signals are shown as fold
enrichment of the percentage of input antibody over the percentage of
input control antibody (IgG) in Ercc1−/− livers over the corresponding ChIP
signals for the WT livers at the H19/Igf2 and Peg3 promoters and ICRs
(n= 3 biological replicates each representing a pool of 4–5 livers per
genotype). Error bars indicate s.e.m. between biological replicates; two-
tailed t-test. The red dotted line indicates the WT. (d) For H19 ICR, ChIP-
isolated P15 bXPF/SPRET/EiJ F1 liver DNA was amplified and digested
with SphI (SPRET/EiJ paternal-specific site) or AcuI (bXPF maternal-specific
site) restriction enzymes. For Peg3 ICR, ChIP-isolated P15 bXPF/SPRET/EiJ
F1 liver DNA was amplified and digested with BstNI (SPRET/EiJ paternal-
specific site) or BaeI (bXPF maternal-specific site) restriction enzymes. Data
are quantified and shown in corresponding graphs (right panel). Error bars
indicate s.d.; n=3 biological replicates. L, ladder; SPRT, SPRET/EiJ; B6,
C57BL/6J; M, maternal; P, paternal, ∗P ≤0.05. Statistical source data are
provided in Supplementary Table 6.
Instead, in Ercc1−/− MEFs, we find that CTCF translocates
to clear subnuclear landmarks identified as heterochromatin
by 4′,-6-diamidine-2-phenylindole (DAPI) and HP1a staining,
occasionally surrounded by the dense fibrillar component of the
nucleolus (Fig. 6a–c and Supplementary Fig. 4A and Supplementary
Fig. 4C). These dense clusters are known to be formed by the
centromeres of different chromosomes that coalesce during
interphase to form chromocentres50. ATRX accumulates to HP1a-
stained heterochromatic regions in Ercc1−/− and to a lesser extent
also in Csbm/m but not in Xpa−/− or Xpc−/− MEFs (Fig. 6d
and Supplementary Fig. 4D). SMC1A accumulates only in the
nucleoplasm of Ercc1−/−MEFs with minimal, sporadic localization to
heterochromatin (Fig. 6e and Supplementary Fig. 4E). SMC3 showed
comparable nuclear and cytoplasmic immunolocalization patterns
across all NER-defective MEFs (Supplementary Fig. 4F). As for MEFs,
we find that CTCF and ATRX accumulate in Ercc1−/− but not in WT
primary hepatocytes (Supplementary Fig. 4G–H). For SMC1A and
CTCF, we find no differences in protein levels between Ercc1−/− and
WT MEFs or in MEFs exposed to MMC (Supplementary Fig. 4B).
To test whether DNA damage directly contributes to the aberrant
localization of CTCF and ATRX in Ercc1−/− MEFs, naive primary
WT MEFs were exposed to UVC, H2O2 and MMC, a potent DNA
crosslinker that, similar to the ERCC1 defect, triggers DNA ICLs
that are efficiently processed by ERCC1–XPF51,52 in a mechanism
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Figure 6 Persistent DNA damage signalling triggers aberrant CTCF
localization and the dissociation of the CTCF–cohesin complex and MBD2
from promoters and ICRs. (a) Immunofluorescence detection of CTCF in WT,
Ercc1−/−, Xpc−/− and Xpa−/− primary MEFs. Note the distinctive translocation
of CTCF to heterochromatin in Ercc1−/− MEFs. (b) Average number of
CTCF-positive stained cells showing CTCF translocation to heterochromatin
following treatment (as indicated by an arrow) from 20 fields analysed;
n= 3 biological replicates. Error bars indicate s.e.m.; two sided t-test.
(c) Immunofluorescence detection of HP1a in MMC-treated and untreated
control MEFs (as indicated by arrows). (d) Immunofluorescence detection of
ATRX in Ercc1−/− and WT primary MEFs. Note the distinctive accumulation
of ATRX to heterochromatin in Ercc1−/− MEFs (indicated with an arrow).
(e) Immunofluorescence detection of SMC1A in WT, Ercc1−/−, Xpc−/− and
Xpa−/− primary MEFs. Note the nucleoplasmic accumulation of SMC1A in
Ercc1−/− MEFs (indicated with arrows). (f) Immunofluorescence detection of
CTCF in primary MEFs exposed to MMC, UV and H2O2. Note the distinctive
translocation of CTCF to heterochromatin in MMC-treated MEFs (indicated by
arrows). (g) Immunofluorescence detection of CTCF in primary MMC-treated
MEFs exposed to ATM (ATMi) or ATR (ATRi) inhibitors. Note the absence of
CTCF translocation to heterochromatin in MMC-treated MEFs exposed to ATMi
(indicated with arrows). (h) Immunofluorescence detection of ATRX in primary
MMC-treated MEFs exposed to ATM (ATMi) inhibitor (see also Supplementary
Fig. 3). Note the absence of ATRX accumulation to heterochromatin in MMC-
treated MEFs exposed to ATMi (indicated with arrows). (i) qPCR mRNA levels
(expressed as fold change to untreated control MEFs) of Igf2, Peg3, Dlk1
and Grb10 genes in primary MEFs exposed to MMC, UV or H2O2 (n=3
biological replicates). Error bars, s.d.; two-tailed t-test. Red dotted line,
mRNA levels of untreated WT MEFs. (j) qPCR mRNA levels (expressed as
fold change (FC) to untreated (Untr.) control MEFs) of Igf2, Peg3, Dlk1
and Grb10 genes in primary MMC-exposed MEFs treated with ATMi or
ATRi (n= 3 biological replicates). Error bars, s.d.; two-tailed t-test. Red
dotted line, mRNA levels of untreated control MEFs. ∗P≤0.05, ∗∗P≤0.01.
Scale bars, 5 µm. Statistical source data are provided in Supplementary
Table 6.
distinct from NER9 and the accumulation of DNA damage-associated
γH2AX foci in the nucleus (Supplementary Fig. 4I). As with
Ercc1−/− MEFs, we find that CTCF and ATRX are predominantly
localized in heterochromatic regions in MMC-treated MEFs but,
importantly, not following exposure of MEFs to UVC irradiation
or to H2O2-induced oxidative DNA damage (Fig. 6f). The γH2AX
foci accumulate only in the nucleoplasm and unlike with CTCF, they
do not appear in the chromocentres of Ercc1−/− and MMC-treated
MEFs (Supplementary Fig. 4I,J). Translocation of CTCF was also
visible in G0 synchronized, serum-starved, MMC-treated MEFs
(Supplementary Fig. 5A). Likewise, ATRX accumulates with CTCF
in heterochromatin of MMC- but not of UVC- or H2O2-treated
cells (Supplementary Fig. 5B,C). In line, we find increased mRNA
levels for all genes tested in MMC- but not in UVC (4 Jm−2)- or
8
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H2O2-treated cells (Fig. 6i); increasedmRNA levels were also detected
at the much higher dose of 10 Jm−2 of UVC probably reflecting
other types of damage53. Similar findings were seen for a larger
subset of imprinted genes in primary MEFs that also show increased
mRNA levels for genes known to be induced following exposure
to 4 Jm−2 of UVC (Supplementary Fig. 6A) or following treatment
with H2O2 (Supplementary Fig. 6B). Inhibition of ATM (ATMi)
with KU-55933 inhibitor54 in MMC-treated MEFs significantly
abrogated the accumulation of CTCF and ATRX in heterochromatin
(Fig. 6g,h). In ATMi-treated cells, we also evidenced the normative
expression levels for Igf2, Peg3, Dlk1 and Grb10 genes compared
with untreated control cells (Fig. 6j). Inactivation of ATR with the
ATR/CDK inhibitor NU6027 in MMC-treated MEFs led to similar
results to those seen following ATM inactivation, albeit to a smaller
magnitude (Fig. 6g,h,j). We find that CTCF does not interact with
components of the Fanconi anaemia, that is, FANCA or FANCD2
and, unlike in Ercc1−/− MEFs (Supplementary Fig. 5D), CTCF does
not translocate to heterochromatin in Fanca−/− or Fancd2−/− MEFs
(Supplementary Fig. 5E). Importantly, exposure of MEFs to MMC
led to substantially reduced ChIP signals on the ICRs/DMR and the
promoters for all genes tested (Fig. 7a and Supplementary Fig. 6C).
With the exception of the Dlk1 promoter, we find normative ChIP
signals for all gene promoters and ICRs/DMR tested in ATMi- and,
in part, also in ATRi-treated MEFs exposed to MMC (Fig. 7a and
Supplementary Fig. 6C), suggesting that such chromatin changes
depend on functional DNA damage response signalling. In line with
Ercc1−/− livers (Fig. 3h), exposure of C57Bl/6/SPRET/EiJ F1 MEFs
to MMC that are polymorphic within the H19 and Peg3 ICRs led to
substantially reduced ChIP signals for CTCF, SMC1A and SMC3 from
the paternal allele (SPRET/EiJ) and the maternal (C57Bl/6) alleles
of Peg3 and the H19 genes, respectively (Fig. 7b and Supplementary
Fig. 7A) and to increased Peg3mRNA levels (Fig. 7c).
As for P15 Ercc1−/− livers, we find the loss of repressive
histone H3K9 trimethylation and H3K27 trimethylation marks on
the ICRs/DMR (Fig. 7d) and promoters (Supplementary Fig. 7B)
in MMC- but not in UVC- or H2O2-treated MEFs. We also find
the concomitant increase of activating acetylated histone H3K9
on the H19 and Peg3 ICRs and on all gene promoters tested
(Supplementary Fig. 7C–D). Abrogation of ATM—and to a lesser
extent also of ATR—led again to normative ChIP signals for
these histone marks compared with untreated MEFs (Fig. 7d and
Supplementary Fig. 7B–D). We find no difference for activating
histone H3K4 trimethylation inH19/Igf2, Peg3,Meg3/Dlk1 andGrb10
ICRs/DMR or promoters in these cells (Supplementary Fig. 7C–D).
DISCUSSION
Using NER-defective animals and an in vivo biotinylation tagging
approach in mice coupled to high-throughput proteomics, our data
link ERCC1–XPF to important regulators of chromatin structure, to
the proper occupancy of CTCF, the cohesin complex, MBD2 and
ATRX at four imprinted loci and to the timely silencing of a subset
of imprinted genes in the developing liver.
Importantly, ERCC1–XPF is not required for the assembly of
the CTCF–cohesin complex and MBD2 in developing Ercc1−/−
livers and is not involved in genome imprinting itself, a process
already established in gametes. However, the heterodimeric complex
is required for the recruitment of the CTCF–cohesin complex, MBD2
andATRX to promoters and ICRs during hepatic development. Unlike
CTCF or ATRX, the ERCC1–XPF complex is found on both alleles of
H19 and Peg3 ICRs. This would allow ERCC1–XPF to interact with
CTCF and/or ATRX for optimal gene silencing during embryogenesis
or postnatal development.
A central aspect of these findings is their possible relevance to
associated developmental disorders. A recently reported patient with
ERCC1 deficiency presented with microcephaly, growth retardation
and neurological abnormalities17. These pathological features also
manifest in patients with CTCF haploinsufficiency55, with Cornelia
de Lange syndrome associated with mutations affecting the cohesin
complex or, intriguingly, the RAD21 protein also involved in double-
strand break repair56 and in male children carrying a mutation
in ATRX 57.
The involvement of CTCF and the cohesin in specific chromatin
loop formation49,58 and the influence of these structures in transcrip-
tional regulation arewell documented36,59. XPG andXPFwere recently
shown to be required for establishing CTCF-dependent chromatin
looping between the promoter and terminator of the activated RARβ2
gene in HeLa cells19,21. This and the data presented herein suggest
a similar role for ERCC1–XPF in facilitating long-range looping,
thereby altering gene expression in the developing liver. The lack of
any comparable defects in the single NER mutant Csbm/m, Xpa−/− or
Xpc−/− livers suggests that this mechanism does not require func-
tional NER.
As for Ercc1−/− mice, exposure of cells to DNA ICLs—but not to
other types of DNA lesion also repaired by NER—triggers chromatin
changes and aberrant histone post-translational modifications
associated with active transcription and the localization of CTCF and
ATRX to heterochromatin. In line, animals carrying inborn defects
in Ercc1, Xpf or Xpg (required for DNA damage incision) are the
only single gene mutations in NER known to manifest with severe
developmental defects60–62. All other single NER mutations result in
phenotypically healthy animals with minor to moderate progeroid
features63. The heterochromatic localization of CTCF and ATRX
was accompanied by the dissociation of the CTCF–cohesin complex,
MBD2 and ATRX from promoters and ICRs in MMC-treated or
Ercc1−/−MEFs and in postnatal Ercc1−/− livers. Inactivation of ATM,
and to a lesser extent of ATR, abolished the DNA damage-driven
accumulation of CTCF and ATRX to heterochromatin, the release
of repressor complexes from promoters and ICRs and the optimal
gene silencing of the active allele. Thus, the DNA damage-driven
reorganization of chromatin structure is reversible and requires
functional DNA damage response. Indeed, the high affinity of the
ERCC1–XPF complex for persistent DNA ICLs64 in MMC-treated
MEFs could trigger the displacement of the heterodimeric complex
from high-order chromatin structures relevant for gene regulation to
DNA damage sites requiring DNA repair (Fig. 7d).
It has been challenging to delineate how DNA damage drives
the onset of tissue-specific, developmental defects. Here, we
provide evidence for a functional link between ERCC1–XPF, DNA
ICLs, chromatin architecture and gene silencing during hepatic
development. Further studies are necessary to reveal how chromatin
organizers respond to DNA damage during development or with
disease onset. 
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Figure 7 A working hypothesis for ERCC1–XPF, DNA damage and aberrant
postnatal expression of imprinted genes during hepatic development.
(a) ChIP signals of CTCF, SMC1A and SMC3 at the H19, Peg3, Meg3
and Grb10 ICRs/DMR in primary MEFs exposed to MMC, UV, H2O2,
or to MMC and ATM or ATR inhibitor (ATMi, ATRi; n = 3 biological
replicates). ChIP signals are shown as in Fig. 5c. For ATMi- and ATRi-
treated MEFs, ChIP signals are compared with MMC-treated MEFs for
significance. Error bars indicate s.e.m. between 3 biological replicates; two-
tailed t-test. (b). Allele-specific ChIP signals of CTCF, SMC1A and SMC3 at
the Peg3 ICR in MMC-treated C57BL/6/SPRET/Eij MEFs (n=3 biological
replicates per genotype). ChIP signals are shown as in Fig. 5a. Error bars
indicate s.e.m. among replicates (n≥3); two-tailed t-test. (c) Allele-specific
mRNA levels for the Peg3 gene in SPRET/EiJ-C57BL/6 MEFs exposed
to MMC; n= 3 biological replicates per genotype. Error bars, s.d.; two-
tailed t-test. ChIP signals are shown as in Fig. 5c. (d) ChIP signals of
repressive H3K27me and H3K9me3 histone marks at the H19, Peg3,
Meg3 and Grb10 ICRs/DMR in primary MEFs exposed to MMC, UV or
H2O2 and in MMC-treated MEFs treated with ATMi or ATRi (n=3 biological
replicates). To test for significance, ChIP signals of MMC-treated MEFs
are compared against untreated cells; ChIP signals of ATMi- and ATRi-
treated MEFs are compared against those of MMC-treated MEFs. Error
bars, s.d.; two-tailed t-test. The red dotted line indicates the untreated
control. (e) A working model for ERCC1–XPF, irreparable DNA ICLs and
aberrant postnatal expression of imprinted genes that are normally silenced
in mammalian development. An inborn defect in ERCC1–XPF leads to
the accumulation of persistent DNA damage (red arrow; ‘1’) triggering
chromatin changes that affect gene expression programs associated with
mammalian development. ERCC1–XPF also maintains a functional role
in chromatin architecture; the heterodimeric complex cooperates with
chromatin organizers to facilitate the postnatal silencing (red arrow; ‘2’)
of a subset of imprinted genes during mammalian development. These
findings suggest an attractive scenario whereby DNA damage in NER-
proficient cells triggers the displacement of the ERCC1–XPF complex from
chromatin structures involved in gene regulation to DNA damage sites
requiring DNA repair. ∗P ≤ 0.05, ∗∗P ≤ 0.01. Statistical source data are
provided in Supplementary Table 6.
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Methods, including statements of data availability and any associated
accession codes and references, are available in the online version of
this paper.
Note: Supplementary Information is available in the online version of the paper
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METHODS
Biotin-tagged XPF and NER mutant animals. To generate the targeting vector
for the insertion/knock-in of the Avi tag cassette before the stop codon of the
last exon of the XPF gene, for the generation of the avXpf knock-in mice, the
following approach was used: PCR products were amplified using Phusion High-
Fidelity DNA Polymerase (NEB). A quadruple ligation reaction was set up using the
fragments: 5′ homology (BamHI/EcoRI 2.1-kb); Avi tag (EcoRI/Hind III 0.18-kb);
lox–neomycin–lox cassette (HindIII/SalI 1.5-kb); pBSSK (BamHI/SalI 2.9-kb). The
3′ homology region (Apa I fragment 2.7-kb) was then subcloned into the vector
followed by cloning of the MC1-TK gene (SacII 1.8-kb) for negative selection.
The final targeting vector was linearized using NotI and used for embryonic stem
cell electroporation. 129/SV embryonic stem cells carrying the Protamine 1-Cre
transgene were maintained in their undifferentiated state (LIF-ESGRO 107 units)
and grown on a feeder layer of gamma-irradiated (3,500 rads) G418r primarymouse
embryonic fibroblasts. Embryonic stem cells (0.8×107) were electroporated (400V,
25 µF) with 50 µg of Not I linearized targeting vector (2mgml−1) and homologous
recombined clones were selected with G418 (300 µgml−1) and ganciclovir (2 µM).
G418-resistant embryonic stem cell clones were subjected to Southern blot analysis
and hybridized with 5′ and 3′ probes from their homology region. Clones with
the correct homologous recombination were expanded to confirm their integrity
and karyotyped to verify their euploid karyotype. Positive clones tested negative
for mycoplasma (Venor GeM) were used for C57/BL6 blastocyst injection to
generate chimaeric mice. Genomic DNA from embryonic stem clones was digested
overnight with BamHI (MINOTECH Biotechnology) and resolved on 1% agarose
gels. Samples were immobilized on Hybond-N+ nylon membranes (Amersham
Bioscience) and hybridized with probes with [32P]dCTP (Izotop). 5′ (1.2-kb SacI)
and 3′ (1.2-kb BglII/Hind III) specific probes flanking the last exon of the XPF
gene were used to identify the targeted (3.4-kb or 4.6-kb) and wild-type allele
(6.6-kb). Chimaeric males were bred to C57BL/6 wild-type females for germ-line
transmission. Offspring were screened by PCR for neo-deletion using primers
F1: 5′-AAGAACTGTCGCTCCCTGATGAAC-3′ and R1 5′-CCTGGGGGGAA
AGAATGAATTGCT-3 ′ (Fig. 1a). Expression of Protamine-1 Cre transgene in
the male germ line resulted in the deletion of the floxed neomycin gene in the
first two out of five pups born, leaving behind a single loxP site after the Avi
tag cassette. The cre recombinase transgene, derived from the PC3 embryonic
stem cell background, was bred out in the process of backcrossing to C57BL/6
mice. The BirA transgenic mice were generated by PCR cloning a 3×HA NLS
BirA cDNA into the HindIII/SalI restriction sites of the A2UCOE-EV-1 construct
(a kind gift from M. Antoniou, Kings College, UK), which comprises the CpG
methylation-free island of the human hnRNPA2B1–CBX3 locus (Supplementary
Fig. 1A), previously shown to drive near-ubiquitous expression of transgenes by
protecting from adverse chromosomal position effects at the sites of transgene
integration26,65. Three independent transgenic lines were established and on the
basis of the expression profile of the BirA transgene (Supplementary Fig. 1A), one
transgenic line was selected for further crosses with the biotin tag XPF knock-
in mice. For allele-specific expression studies, F1 pups were obtained by mating
SPRET/EiJ male mice (The Jackson Laboratory) with Mus musculus female mice
(bXPF). The generation and characterization of NER-deficient Csbm/m, Xpa−/−,
Csbm/m; Xpa−/−, Ercc1−/− and XpdTTD mice has been previously described11. With
the exception of Ercc1−/− mice, which were generated in an FVB:C57BL/6J (50:50)
genetic background, all mice were in a C57BL/6J genetic background. Animals
were kept on a regular diet and housed at the IMBB animal house, which operates
in compliance with the ‘Animal Welfare Act’ of the Greek government, using the
‘Guide for the Care and Use of Laboratory Animals’ as its standard. As required
by Greek law, formal permission to generate and use genetically modified animals
was obtained from the responsible local and national authorities. All animal studies
were approved by independent Animal Ethical Committees at FORTH and BSRC
Al. Fleming.
Mass spectrometry studies. Proteins eluted from the beads were separated by SDS–
PAGE electrophoresis on a 10% polyacrylamide gel and stained with colloidal blue
silver (ThermoFisher Scientific). The entire lane was cut out and divided into at least
20 gel plugs, which were each further reduced to 1mm3 gel pieces and placed in
low-bind tubes (Eppendorf UK). Proteins were in-gel-digested by using modified
trypsin (Roche Diagnostics) in 50mM ammonium bicarbonate. Peptide mixtures
were analysed by nLC-ESI-MS/MS on a LTQ-Orbitrap XL coupled to an Easy nLC
(Thermo Scientific). The sample preparation and the nLC-ESI-MS/MS analysis
were performed as previously described66 with minor modifications. Briefly, the
dried peptides were dissolved in 0.5% formic acid aqueous solution, and the tryptic
peptide mixtures were separated on a reversed-phase column (Reprosil Pur C18
AQ, Dr. Maisch GmbH), fused silica emitters 100mm long with a 75 µm internal
diameter (ThermoFisher Scientific) packed in-house using a packing bomb (Loader
kit SP035, Proxeon). Tryptic peptides were separated and eluted in a linear water–
acetonitrile gradient and injected into the MS.
Cells, colony formation and unscheduled DNA synthesis assays. Primary MEFs
(P4) were cultured in standard medium containing Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 50 µgml−1
streptomycin, 50Uml−1 penicillin (Sigma) and 2mM L-glutamine (Gibco). MEFs
were rinsed with PBS, exposed to UVC irradiation (10 Jm−2), H2O2 (10 µM) or
MMC (10 µgml−1) (Applichem) and cultured at 37 ◦C for 4 h prior to ChIP-qPCR,
mRNA expression or immunofluorescence experiments. For ATM or ATR kinase
inhibitor assays, cells were treated for 1 h with 10 µM inhibitor (Millipore) followed
by the addition of MMC. For cell survival experiments, a total of 100–200 primary
MEFs were seeded in 10 cm Petri dishes. The next day, the cells were exposed
to MMC treatment for 4 h or to UVC irradiation and incubated for 10 days.
Colonies were stained with Coomassie blue (0.2% Coomassie blue, 50% methanol,
7% acetic acid), and the number of colonies was counted and expressed as a
percentage of the treated cells relative to that of the untreated control. At least three
independent survival experiments were performed using three dishes per dose. DNA
repair synthesis was determined by 5-ethynyl-2′-deoxyuridine (EdU) incorporation.
Primary MEFs grown on coverslips were globally UVC irradiated and incubated
for 2 h in medium supplemented with 10 µM EdU. After EdU incorporation, cells
were washed with PBS followed by fixation with 2% formaldehyde in PBS. The
coverslips were blocked for 30min with 10% FBS in PBS, followed by 1 h incubation
with 10mM sodium ascorbate and 4mM CuSO4 containing Alexa Fluor594 azide
(ThermoFischer Scientific A10270) andDAPI staining. The number of EdU-positive
cells among 200 cells was counted, and the percentage of EdU-positive cells relative
to the total number of cells was calculated.
Immunofluorescence, antibodies, westerns blots, co-immunoprecipitation, ChIP,
ChIP/re-ChIP and chromatin pulldown assays. Immunofluorescence experiments
were performed as previously described46,53. Briefly, cells (primary MEFs) were
plated in 60mm plates and cultured in standard medium containing DMEM
supplemented with 10% FBS or for serum starvation with 1% FBS, 50 µgml−1
streptomycin, 50 Uml−1 penicillin (Sigma) and 2mM L-glutamine (Gibco). Primary
hepatocytes were obtained from 15-day-old mice. Livers were minced, digested
with collagenase type IV at 37 ◦C for 30min and cells were plated to attach on
coverslips at 37 ◦C, followed by immunostaining. Primary MEFs (passage 4; P4)
were exposed to DNA-damaging agents for ChIP-qPCR, mRNA expression or
immunofluorescence experiments. Cells were rinsed with PBS, exposed to UVC
light (10 Jm−2), H2O2 (10 µM) or mitomycin C (MMC; 10 µgml−1) (Applichem)
and cultured at 37 ◦C for 4 h. For ATM or ATR kinase inhibitor assays, cells
were treated for 1 h with 10 µM inhibitor (Millipore) followed by the addition
of MMC. Nuclear protein extracts from 15-day-old livers or cells were prepared
as previously described10 using the high-salt extraction method (10mM HEPES–
KOH pH 7.9, 380mM KCl, 3mM MgCl2, 0.2mM EDTA, 20% glycerol and
protease inhibitors). For immunoprecipitation (IP) assays, nuclear lysates were
diluted threefold by adding ice-cold HENG buffer (10mM HEPES–KOH pH 7.9,
1.5mM MgCl2, 0.25 mM EDTA, 20% glycerol) and precipitated with antibodies
overnight at 4◦C followed by incubation for 3 h with protein G–Sepharose beads
(Millipore). Normal mouse or rabbit IgG (Santa Cruz) was used as a negative
control. Immunoprecipitates were washed five times (10mM HEPES–KOH pH
7.9, 300mM KCl, 0.3% NP40, 1.5mM MgCl2, 0.25mM EDTA, 20% glycerol and
protease inhibitors), eluted and resolved on 8% or 10% SDS–PAGE. Pulldowns
were performed with 1.5–1.7mg of nuclear extracts using M-280 paramagnetic
streptavidin beads (Invitrogen) as previously described23. For ChIP assays, tissues
or cells were crosslinked at room temperature for 5 or 2.5min respectively with
1% formaldehyde. Chromatin was prepared and sonicated on ice for 15min using
a Covaris S220 Focused-ultrasonicator. Samples were immunoprecipitated with
antibodies (5–6 µg) overnight at 4 ◦C followed by incubation for 3 h with protein
G–Sepharose beads (Millipore) and washed sequentially. The complexes were eluted
and the crosslinking was heat reversed. Purified DNA fragments were analysed by
qPCR using sets of primers (primer sequences are listed in Supplementary Table 5)
targeting different regions of Igf2, Peg3, Dlk1 and Grb10 genes. ChIP re-ChIP
experiments were performed as described above with the following modifications
after the first immunoprecipitation andwashing: complexes were eluted with 10mM
dithiothreitol, 1% SDS in TE buffer for 30min. Eluted samples were diluted 1:20
with re-ChIP buffer (10mM Tris-HCl pH 8, 1mM EDTA, 150mM NaCl, 0.01%
SDS and 1% Triton X-100) and immunoprecipitated overnight with the secondary
antibody. Antibodies against HA (Y-11, western blotting (wb): 1:500), TFIIB (C-
18, wb: 1:500), ERCC1 (D-10, wb: 1:500), ATRX (H-300, immunofluorescence
(IF): 1:50) were from SantaCruz Biotechnology. γH2AX (05-636, IF: 1:12,000)
and CTCF (07-729, wb: 1:1,000), H3K9Ac (07-352) and H3K27me3(07-449) were
from Millipore. CTCF (clone 48, wb: 1:500, IF: 1:100) was from BD Transduction
Laboratories. SMC1A (A300-055A, wb: 1:4,000, IF: 1:200), SMC3 (A300-060A,
wb: 1:4,000, IF: 1:100) and MBD2 (A301-633A, wb: 1:500) were from Bethyl
Laboratories. Streptavidin-HRP (wb: 1:12,000) was from Upstate Biotechnology.
Nucleolin (ab22758, IF: 1:2,000), H3K4me3 (ab8580) and H3K9me3 (ab6001) were
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from Abcam. Flag M2 (F3165, wb 1:2,000) was from Sigma-Aldrich. HP1a (2HP-
1H5, IF: 1:200) was from Chemicon.
Gene expression studies. Microarray gene expression data on P15 NER-deficient
(that is, Csbm/m;Xpa−/−, XpdTTD, Ercc1−/−) and age-matched littermate control livers
(Csbm/m, Xpa−/− and WT) were collected from cited sources23,30,40. Total RNA was
isolated from liver, heart, kidney, spleen and lung of P15 Ercc1−/− mice using a
Total RNA isolation kit (Qiagen) as described by the manufacturer. Quantitative
PCR (qPCR) was performed with a DNA Engine Opticon device according to the
instructions of the manufacturer (MJ Research). The generation of specific PCR
products was confirmed by melting curve analysis and gel electrophoresis. Each
primer pair was tested with a logarithmic dilution of a cDNAmix to generate a linear
standard curve (crossing point (CP) plotted versus log of template concentration),
whichwas used to calculate the primer pair efficiency (E=10(−1/slope)).Hypoxanthine
guanine phosphoribosyltransferase1 (Hprt-1) mRNA was used as an external
standard. For data analysis, the second derivative maximum method was
applied: (E1CP(cDNA of WT mice-cDNA of Ercc1
-/- , Xpa-/- or Csbm/m or Csbm/m/Xpa-/-) gene of interest
1gene of interest )/
(E1CP (cDNAWTmice-cDNA of Xpa
-/- or Csbm/m or Csbm/m/Xpa-/-) hprt-1
hprt-1 ). Primer sequences are listed in
Supplementary Table 5.
Allele-specific ChIP analysis. Allele-specific ChIP analysis was performed on P15
bXPF(C57BL/6)-SPRET/EiJ F1 livers. PCR amplification using unbiased primers
was performed for the H19 and Peg3 ICR regions. The amplified product was
purified and subsequently digested with specific restriction enzymes for 2 h. The
digested DNA was resolved on a 2% agarose gel and visualized using an ultraviolet
transilluminator (BioRad). Primer sequences are available in Supplementary Table 5.
Allele-specific sequences were retrieved from the Mouse Genomes Project (Sanger
Institute) and primers were designed with Batch Primer 3.0. All sets of primers were
validated for allele specificity by qPCR amplification of strain/species pure or mixed
genomic DNA from C57BL/6NJ, FVB/NJ and SPRET/Eij.
Bisulfite mutagenesis. Genomic DNA isolated from P15 livers of Ercc1−/− and
littermate control mice was mutagenized with sodium bisulfite by using an EpiTect
Bisulfite Conversion Kit (QIAGEN) according to the manufacturer’s instructions.
PCR amplification was carried out with primers specific for bisulfite-treated DNA.
Primer sequences are available in Supplementary Table 5. All promoter and DMR
regions were amplified by PCR. The resulting PCR products were ligated into
the pCRII vector using a TOPO-TA cloning kit (Invitrogen), according to the
manufacturer’s instructions. Positive clones were sequenced, and clones were only
accepted at >94% cytosine conversion. To ensure that the selected clones were
derived from a unique DNA template we used non-converted cytosines and
mismatched base pairs as reference points for each clone.
Data analysis. A two-tailed t-test was used to extract the statistically significant
data by means of the IBM SPSS Statistics 19 (IBM), Spotfire (Tibco), Partek
(Partek INCoR1porated) and R-statistical package (www.r-project.org). Significant
over-representation of pathways and gene networks was determined by DAVID
(http://david.abcc.ncifcrf.gov/summary.jsp; through BBID, BIOCARTA and KEGG
annotations) as well as by means of the Ingenuity Pathway Analysis software
(www.ingenuity.com). For mass spectrometry (MS), the MS/MS raw data were
loaded in Proteome Discoverer 1.3.0.339 (ThermoFischer Scientific) and run using
the Mascot 2.3.02 (Matrix Science) search algorithm against the Mus musculus
theoretical proteome (last modified 6 July 2015) containing 46,470 entries in
Uniprot. A list of common contaminants was included in the database67. For protein
identification, the following search parameters were used: precursor error tolerance
10 ppm, fragment ion tolerance 0.8Da, trypsin full specificity, maximum number of
missed cleavages 3 and cysteine alkylation as a fixedmodification. The resulting .dat
and .msf files were subsequently loaded and merged in Scaffold (version 3.04.05,
Proteome Software) for further processing and validation of the assigned MS/MS
spectra. Thresholds for protein and peptide identification were set to 99% and 95%
accordingly, for proteins with minimum 1 different peptides identified, resulting in
a protein false discovery rate (FDR) of <0.1%. For single peptide identifications,
we applied the same criteria in addition to manual validation of MS/MS spectra.
Protein lists were constructed from the respective peptide lists through extensive
manual curation based on previous knowledge. For label-free relative quantitation of
proteins, we applied a label-free relative quantitation method between the different
samples (control versus bait) to determine unspecific binders during the affinity
purification. All .dat and .msf files created by Proteome Discoverer were merged
in Scaffold where label-free relative quantification was performed using the total ion
current (TIC) from each identified MS/MS spectra. The TIC is the sum of the areas
under all the peaks contained in a MS/MS spectrum and total TIC value results by
summing the intensity of the peaks contained in the peak list associated to a MS/MS
sample. Protein lists containing the Scaffold-calculated total TIC quantitative value
for each protein were exported to Microsoft Excel for further manual processing
including categorization and additional curation based on previous knowledge.
The fold change of protein levels was calculated by dividing the mean total TIC
quantitative value in bait samples with themean value of the control samples for each
of the proteins. Proteins having ≥60% protein coverage, ≥1 peptide in each sample
and a fold change≥1.2 in all threemeasurements were selected as being significantly
enriched in bXPF compared with BirA liver samples. Proteins that were significantly
enriched in bait samples were considered these with P value≤0.05 and a fold change
≥2. Significant over-representation of pathways, protein–protein interactions and
protein complexes were derived by STRING68 (http://string-db.org).
Statistics and reproducibility. Experiments were repeated at least 3 times. The data
exhibited normal distribution (where applicable). There was no estimation of group
variation before experiments. Error bars indicate standard deviation unless stated
otherwise, that is, s.e.m. For animal studies, each biological replicate consists of
3–5 mouse tissues or cell cultures per genotype per time point or treatment. No
statistical method was used to predetermine sample size. None of the samples or
animals was excluded from the experiment. The animals or the experiments were not
randomized. The investigators were not blinded to allocation during experiments
and outcome assessment. The representative images shown in Figs 1d–f,i, 2a, 3a,b,f,
4c, 5b,d and 6a,c–h and Supplementary Figs 1A,B, 2B–G, 4 and 5 have been repeated
more than 3 times.
Data availability. Previously published microarray data that were reanalysed here
are available under accession codes E-MEXP-3930 and E-MEXP-835 (ref. 23,
30,40). The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via
the PRIDE partner repository69 with the data set identifier PXD005897. Source
data for Figs 1 and 3–7 and Supplementary Figs 1, 3, 4, 6 and 7 have been
provided as Supplementary Table 6 (Statistics source data). All other data supporting
the findings of this study are available from the corresponding author on
reasonable request.
65. Antoniou, M. et al. Transgenes encompassing dual-promoter CpG islands from
the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated
silencing. Genomics 82, 269–279 (2003).
66. Aivaliotis, M. et al. Large-scale identification of N-terminal peptides in the halophilic
archaea Halobacterium salinarum and Natronomonas pharaonis. J. Proteome Res. 6,
2195–2204 (2007).
67. Rappsilber, J., Ryder, U., Lamond, A. I. & Mann, M. Large-scale proteomic analysis
of the human spliceosome. Genome Res. 12, 1231–1245 (2002).
68. Szklarczyk, D. et al. The STRING database in 2011: functional interaction
networks of proteins, globally integrated and scored. Nucleic Acids Res. 39,
D561–D568 (2011).
69. Vizcaino, J. A. et al. The PRoteomics IDEntifications (PRIDE) database and
associated tools: status in 2013. Nucleic Acids Res. 41, D1063–D1069 (2013).
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
NATURE CELL BIOLOGY
S U P P L E M E N TA RY  I N F O R M AT I O N
WWW.NATURE.COM/NATURECELLBIOLOGY 1
DOI: 10.1038/ncb3499
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
In the format provided by the authors and unedited.
Supplementary Figure 1 Ablation of Ercc1 gene triggers the aberrant silenc-
ing of imprinted genes during postnatal hepatic development. (A). Sche-
matic representation of transgenic mice expressing the BirA biotin ligase 
transgene and anti-HA immunoblot showing expression of the BirA biotin 
ligase protein in different tissues of 2-month old BirA transgenic animals (as 
indicated). (B). Streptavidin pull-downs in nuclear or chromatin extracts un-
der native (micrococcal nuclease digested) conditions derived from primary 
bXPF MEFs expressing the BirA transgene or the BirA transgenic animals (as 
indicated) and analysed by Western blotting for CTCF. (C). Over-represent-
ed biological processes derived from the significantly aberrantly expressed 
imprinted genes  in P15 Ercc1-/- compared to age-matched wt livers; p: -log 
of p-value which is calculated by Fisher’s exact test right-tailed. Red dotted 
line marks the threshold of significance at 0.05. (D). qPCR mRNA levels of 
imprinted genes in P15 Ercc1-/- spleen, kidney, white adipose tissue (WAT), 
pancreas and cerebellum (as indicated; n=3 biological replicates each rep-
resenting a pool of 4-5 tissues/genotype). Red dotted line: wt mRNA levels. 
Error bars indicate S.D; two tailed t-test. Statistical source data are provided 
in Table S6. 
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Supplementary Figure 2 DNA methylation at the Igf2, Peg3, Dlk1 and Peg3 
proximal promoter regions in Ercc1-/- livers. (A). ChIP-seq profiles marking 
the recruitment of CTCF and RNAPII (Pol2) at the H19, Dlk1, Peg3 and 
Grb10 promoter and ICRs/DMR regions in livers (liv) or mouse embryonic 
fibroblasts (MEFs) as indicated. Arrow heads mark the PCR amplified ICR or 
promoter (prom) regions (as indicated). (B-G). Schematic representation of 
the % of DNA methylation at the Peg3 (promoter), Grb10 (CTCF-peak), Igf2 
(promoter 2 and 3), Grb10 (promoter) and Meg3 (ICR) regions (as indicated) 
in P15 Ercc1-/- and wt livers. Black circles: methylated cytosine; open cir-
cles: unmethylated cytosine. 
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Supplementary Figure 3 Dissociation of the CTCF-cohesin complex and 
MBD2from the promoters and ICRs of imprinted genes in Ercc1-/- livers. (A). 
bXPF, CTCF, SMC1A, SMC3, MBD2 and ATRX ChIP signals expressed as fold 
enrichment over those obtained with BirA (for bXPF) or control antibody (IgG) 
at the Igf2, Peg3, Dlk1 and Grb10 promoters in P15 wt mouse livers (as indi-
cated; n=3 biological replicates each representing a pool of 4-5 livers). Error 
bars indicate S.E.M. among replicates (n ≥ 3). (B). ChIP signals shown as % 
of input of CTCF, SMC1A, SMC3, MBD2 and ATRX at the Igf2, Peg3, Meg3 
and Grb10 ICR regions and CTCF negative (-) regions (as indicated; n=3 bi-
ological replicates each representing a pool of 4-5 livers). Error bars indicate 
S.E.M. (C). CTCF, SMC1A, SMC3, MBD2 and ATRX ChIP signals normalized 
against their respective control antibody (IgG) and expressed as fold enrich-
ment over the corresponding ChIP signals obtained for wt mouse livers at 
the Dlk1/Meg3 and Grb10 promoters and ICRs (as indicated; n=3 biological 
replicates each representing a pool of 4-5 livers). Error bars indicate S.E.M., 
*: p≤0.05; two-tailed t-test. Statistical source data are provided in Table S6.
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Supplementary Figure 4 Persistent DNA ICLs trigger aberrant CTCF and 
ATRX localization in Ercc1-/- and MMC-treated MEFs. (A). Immunofl uores-
cence detection of CTCF in Csbm/m primary mouse embryonic fi broblasts 
(MEFs; 20 fi elds analysed from 3 biological replicates). (B). Equal amount 
of nuclear extracts from wt, MMC-treated and Ercc1-/- MEFs analysed by 
Western blotting for CTCF, SMC1A and TBP. (C). Immunocolocalization of 
CTCF and HP1a in MMC-treated and untreated P4 MEFs. (D). Immunofl u-
orescence detection of ATRX in Ercc1-/-, Csbm/m, Xpc-/- and Xpa-/- primary 
mouse embryonic fi broblasts (MEFs; 20 fi elds analysed from 3 biological 
replicates). Note the distinctive accumulation of ATRX to heterochromatin 
in Ercc1-/- MEFs. (E). Immunofl uorescence detection of SMC1A in primary 
Csbm/m MEFs. (F). Immunofl uorescence detection of SMC3 in wt, Ercc1-/-, 
Csbm/m, Xpc-/- and Xpa-/- primary MEFs (as indicated; 20 fi elds analysed 
from 3 biological replicates). (G-H). Immunofl uorescence detection of CTCF 
and ATRX in primary wt and Ercc1-/- hepatocytes; note the distinctive trans-
location of CTCF and accumulation of ATRX to heterochromatin Ercc1-/- he-
patocytes. (I). Immunofl uorescence detection of γH2aX and nucleolin in 
wt  and Ercc1-/-  MEFs (upper panel) and in MMC-treated and untreated 
control (ctrl) MEFs (lower panel); the graph depicts the average number of 
γH2aX-positive stained cells in wt and Ercc1-/- MEFs or wt MEFs exposed 
to MMC from 20 fi elds analysed representing n=3 biological replicates*: 
P-value≤0.05. (J). Immunocolocalization of CTCF and γH2aX in MMC-treat-
ed and untreated P4 MEFs. Scale bars, 5 μm. Statistical source data are 
provided in Table S6.
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Supplementary Figure 5 Persistent DNA ICLs trigger aberrant CTCF and 
ATRX localization in Ercc1-/- and MMC-treated MEFs. (A). Immunofluores-
cence detection of CTCF in serum starved (SS) MEFs exposed to MMC (as 
indicated; 20 fields analysed from 3 biological replicates).  (B). Immuno-
fluorescence detection of ATRX in primary MEFs exposed to MMC, UV and 
H202; Ctr: untreated MEFs. Note the distinctive accumulation of ATRX to 
heterochromatin in MMC-treated MEFs. (C). Immunocolocalization of CTCF 
and ATRX in MMC-treated primary P4 MEFs. (D). Co-immunoprecipitation 
experiments using αCTCF in nuclear extracts from P15 livers analysed by 
Western blotting for FANCA or FANCD2. (E). Immunofluorescence detection 
of CTCF in Fanca-/- and Fancd2-/- MEFs (as indicated; 20 fields analysed 
from 3 biological replicates). Scale bars, 5 μm. 
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Supplementary Figure 6 Persistent DNA ICLs trigger the dissociation of the 
CTCF-cohesin complex and MBD2 from promoters and ICRs. (A). Quantita-
tive (q) PCR mRNA levels of UV-responsive and imprinted genes in primary 
mouse dermal fibroblasts exposed to 0.6 and 4 J/m2 of UVC irradiation (as 
indicated), n= 3 biological replicates/dose. Error bars indicate S.D. (B). 
qPCR mRNA levels of H202-responsive and imprinted genes in primary 
mouse dermal fibroblasts treated with 10μM or 50μM of H202 (as indi-
cated), n= 3 biological replicates/dose. Error bars indicate S.D. (C). ChIP 
signals of CTCF, SMC1A and SMC3 (as indicated) at the H19, Peg3, Dlk1 
and Grb10  promoters in primary MEFs exposed to UV, H202 and MMC or 
to MMC and ATM or ATR inhibitors (ATMi, ATRi as indicated). ChIP signals 
from treated MEFs were normalized to respective control antibody (IgG) 
which were set as 1 (red dotted line) and expressed as fold enrichment 
over those obtained from untreated MEFs,  n= 3 biological replicates. Error 
bars indicate S.D.; two-sided t-test. Statistical source data are provided in 
Table S6. 
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Supplementary Figure 7 Persistent DNA ICLs trigger changes in histone marks 
associated with aberrant postnatal silencing. (A). Allele-specific ChIP signals 
of CTCF, SMC1A and SMC3 (as indicated) at the H19 ICR in MMC-treated 
C57BL/6 /SPRET/Eij MEFs (as indicated). ChIP signals expressed as fold 
enrichment over those obtained with control antibody (IgG). Error bars indi-
cate S.D. among biological replicates; (n = 3 biological replicates). (B). ChIP 
signals of repressive H3K27me and H3K9me3 histone marks at the H19, 
Peg3, Dlk1 and Grb10 promoters in primary MEFs exposed to MMC, UV or 
H202 (as indicated) and in MMC-treated MEFs treated with ATMi or ATRi (as 
indicated). ChIP signals are shown as in Figure 5C. To test for significance, 
ChIP signals of ATMi and ATRi-treated MEFs are compared against those of 
MMC-treated MEFs; two sided t-test. (C-D). ChIP signals of activating H3K-
9Ac and H3K4me3 histone marks at the H19/Igf2, Peg3, Meg3/Dlk1 and 
Grb10 ICRs and promoters in primary MEFs exposed to MMC, UV or H202 (as 
indicated) and in MMC-treated MEFs treated with ATMi or ATRi (as indicat-
ed; n=3 biological replicates). ChIP signals are shown as in Figure 5C. To test 
for significance, ChIP signals of MMC-treated MEFs are compared against 
untreated cells; ChIP signals of ATMi and ATRi-treated MEFs are compared 
against those of MMC-treated MEFs. **: P≤ 0.01, Error bars indicate S.D.; 
two-sided t-test. Statistical source data are provided in Table S6. 
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Supplementary Figure 8 Unprocessed scanned Western blots. (A). Unprocessed images of the western blots shown in Figure 2A. (B). Unprocessed images of 
the western blots shown in Figure 3Ai, ii, iii and iv (as indicated). 
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Supplementary Table legends
Supplementary Table 1 Overview of the 306 XPF-bound proteins in P15 bXPF (bX) and birA (br) control livers.  
Supplementary Table 2  Overview of the 140 shared XPF-bound proteins from the two measurements of P15 bXPF (bX) and birA (br) control livers.
Supplementary Table 3  Overview of the expression profiles of 68 imprinted genes in P15 NER-deficient livers vs. age-matched wt controls. A: allele; FC: 
Fold Change; P: p-value.
Supplementary Table 4 Overview of imprinted genes with significantly aberrant gene expression profiles in P15 NER-deficient livers as compared to age-
matched wt controls. Al: allele; FC: Fold Change; P: p-value.
Supplementary Table 5 Primer sequences. Primer sequences for mRNA and allele specific gene expression, bisulfite mutagenesis, ChIP and allele-specific 
ChIP qPCR assays and targeting vector.
Supplementary Table 6 Statistics source data.
